| Literature DB >> 27241336 |
Christopher W Jensen1, Andrew B Goldstone1, Y Joseph Woo2,3.
Abstract
This review will discuss the medical management of pulmonary hypertension in patients with left ventricular assist devices. Although much has been written on the management of primary pulmonary hypertension, also called pulmonary arterial hypertension, this review will instead focus on the treatment of pulmonary hypertension secondary to left heart disease. The relevant pharmacotherapy can be divided into medications for treating heart failure, such as diuretics and β-blockers, and medications for treating pulmonary hypertension. We also discuss important preoperative considerations in patients with pulmonary hypertension; the relationships between left ventricular assist devices, pulmonary hemodynamics, and right heart failure; as well as optimal perioperative and long-term postoperative medical management of pulmonary hypertension.Entities:
Keywords: Bosentan; Left heart failure; Nitric oxide; Pulmonary hypertension; Sildenafil; Ventricular assist device
Mesh:
Year: 2016 PMID: 27241336 DOI: 10.1007/s11897-016-0288-6
Source DB: PubMed Journal: Curr Heart Fail Rep ISSN: 1546-9530